Search Browse Earnings

scPharmaceuticals Inc. — SlamSEC

scPharmaceuticals Inc.

Pharmaceutical Preparations·BURLINGTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$13.6M

+0.0% YoY

FY 2024

Adj. EBITDA

-$55.4M

-407.4% margin

FY 2024

Net Income

-$54.8M

-403.2% margin

FY 2024

EPS (Diluted)

-$1.42

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$46.8M

FY 2024

Total Debt

$38.8M

FY 2024

Net Cash

$8.0M

FY 2024

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2024

EV / EBITDA

—

Employees

—